Public awareness in Wales of the UK Yellow Card scheme for reporting suspected adverse drug reactions

Robert C. Bracchi, Foteini Tseliou*, Lauren Copeland, Philip A. Routledge, Alison Thomas, Fiona Woods, Alana Adams, Jenna Walker, Mitul Jadeja, Mark D. Atkinson, Pauline Ashfield-Watt

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

6 Citations (Scopus)

Abstract

We used the HealthWise Wales (HWW) platform to explore public knowledge about the UK Yellow Card scheme (YCS), the spontaneous reporting scheme for suspected adverse drug reactions (ADRs) and whether a short information video could improve awareness. Members of the public in Wales (n = 1606) completed a questionnaire about the YCS, watched the information video and then completed a follow-up questionnaire. Almost half (46.5%) of respondents said they had previously experienced an ADR (>90% of the ADRs involving prescribed medicines). Before the video, 18% of respondents knew how to report an ADR via the YCS and of these, 34% were from allied-health professions. Immediately after watching it, 71% participants reported knowing how to report and 82% reported being confident to report. If this awareness were maintained, such an approach could contribute to improved reporting of suspected ADRs by the public.

Original languageEnglish
Pages (from-to)3344-3348
Number of pages5
JournalBritish Journal of Clinical Pharmacology
Volume87
Issue number8
DOIs
Publication statusPublished - 2 Jan 2021
Externally publishedYes

Keywords

  • Yellow Card scheme
  • adverse drug reactions
  • public awareness

Cite this